United StatesCongress
hr 8641Bill

Orphan Drug COVID–19 Mitigation Act of 2022

To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic for the development of orphan drugs, and for other purposes.

Introduced on August 2, 2022

House
Senate
President